Correlation Between Oric Pharmaceuticals and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oric Pharmaceuticals and Akero Therapeutics, you can compare the effects of market volatilities on Oric Pharmaceuticals and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Akero Therapeutics.
Diversification Opportunities for Oric Pharmaceuticals and Akero Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oric and Akero is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Oric Pharmaceuticals and Akero Therapeutics
Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 23.72 times less return on investment than Akero Therapeutics. But when comparing it to its historical volatility, Oric Pharmaceuticals is 1.57 times less risky than Akero Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Akero Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,789 in Akero Therapeutics on November 3, 2024 and sell it today you would earn a total of 3,619 from holding Akero Therapeutics or generate 202.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oric Pharmaceuticals vs. Akero Therapeutics
Performance |
| Timeline |
| Oric Pharmaceuticals |
| Akero Therapeutics |
Oric Pharmaceuticals and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oric Pharmaceuticals and Akero Therapeutics
The main advantage of trading using opposite Oric Pharmaceuticals and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Oric Pharmaceuticals vs. Seer Inc | Oric Pharmaceuticals vs. Anebulo Pharmaceuticals | Oric Pharmaceuticals vs. Cullinan Oncology LLC | Oric Pharmaceuticals vs. C4 Therapeutics |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |